Citation Impact

Citing Papers

Cardiac Hypertrophy: The Good, the Bad, and the Ugly
2003 Standout
Keeping G Proteins at Bay: A Complex Between G Protein-Coupled Receptor Kinase 2 and Gßγ
2003 StandoutScienceNobel
β-Arrestin-dependent, G Protein-independent ERK1/2 Activation by the β2 Adrenergic Receptor
2005 StandoutNobel
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
Protein Kinase A and G Protein-coupled Receptor Kinase Phosphorylation Mediates β-1 Adrenergic Receptor Endocytosis through Different Pathways
2003 StandoutNobel
Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy
2001 StandoutNobel
The Identity and Regulation of the Mitochondrial Permeability Transition Pore
2008
Mixed signals in heart failure: cancer rules
2002
β-Arrestin Scaffolding of Phosphatidylinositol 4-Phosphate 5-Kinase Iα Promotes Agonist-stimulated Sequestration of the β2-Adrenergic Receptor
2008 StandoutNobel
Genotype, phenotype: upstairs, downstairs in the family of cardiomyopathies
2003
Heme oxygenase-1 overexpression exacerbates heart failure with aging and pressure overload but is protective against isoproterenol-induced cardiomyopathy in mice
2014
Calcium signalling: dynamics, homeostasis and remodelling
2003 Standout
Antithetic regulation by β-adrenergic receptors of Gq receptor signaling via phospholipase C underlies the airway β-agonist paradox
2003 StandoutNobel
Prospects for Cardiovascular Research
2001 StandoutNobel
Early cardiac hypertrophy in mice with impaired calmodulin regulation of cardiac muscle Ca2+ release channel
2007 StandoutNobel
Association of phospholamban with a cGMP kinase signaling complex
2003
Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies
2010
The Genetic Basis for Cardiomyopathy
2001
Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration
2003 Standout
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A–deficient mice
2001 StandoutNobel
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
Cardiac hypertrophy and failure: lessons learned from genetically engineered mice
2001
Decoding calcium signals involved in cardiac growth and function
2000
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human
2003
Super-Enhancers in the Control of Cell Identity and Disease
2013 Standout
ErbB2 is essential in the prevention of dilated cardiomyopathy
2002
Metazoan MicroRNAs
2018 Standout
Modeling β-Adrenergic Control of Cardiac Myocyte Contractility in Silico
2003
A myocardial lineage derives from Tbx18 epicardial cells
2008 StandoutNature
Regulation of β-Adrenergic Receptor Signaling by S-Nitrosylation of G-Protein-Coupled Receptor Kinase 2
2007 StandoutNobel
Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy
2003
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Abnormalities of Calcium Cycling in the Hypertrophied and Failing Heart
2000
Myocarditis
2011 Standout
Phospholamban and Cardiac Contractile Function
2000
β2-Adrenergic Receptor Signaling and Desensitization Elucidated by Quantitative Modeling of Real Time cAMP Dynamics
2007 StandoutNobel
Fibulin-5/DANCE is essential for elastogenesis in vivo
2002 StandoutNatureNobel
β-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection
2007 StandoutNobel
Seven-transmembrane-spanning receptors and heart function
2002 StandoutNatureNobel
Adult mice deficient in actinin–associated LIM-domain protein reveal a developmental pathway for right ventricular cardiomyopathy
2001
β-Adrenergic receptors in the failing heart: the good, the bad, and the unknown
2001
Converging Pathways and Principles in Heart Development and Disease
2002
Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice
2003 StandoutNobel
Excitation-contraction coupling and mitochondrial energetics
2007
Dynamics of the Upper 50-kDa Domain of Myosin V Examined with Fluorescence Resonance Energy Transfer
2005 StandoutNobel
Genetic causes of human heart failure
2005
A decade of discoveries in cardiac biology
2004
Cardiac excitation–contraction coupling
2002 StandoutNature
Rescue of Contractile Parameters and Myocyte Hypertrophy in Calsequestrin Overexpressing Myocardium by Phospholamban Ablation
2001
Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo
2006 StandoutNobel
Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy
2003
Mixed signals in heart failure: cancer rules
2002
Control of inositol 1,4,5-trisphosphate-induced Ca2+ release by cytosolic Ca2+
1995 Standout
Genomic circuits and the integrative biology of cardiac diseases
2000 Nature
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Cardiac hypertrophy and sudden death in mice with a genetically clamped renin transgene
2004 StandoutNobel
Genotype, phenotype: upstairs, downstairs in the family of cardiomyopathies
2003
Systems analysis of PKA-mediated phosphorylation gradients in live cardiac myocytes
2006 StandoutNobel
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
THE GENETIC BASIS FOR CARDIAC REMODELING
2005
Arrhythmogenesis and Contractile Dysfunction in Heart Failure
2001
MEKK1 is essential for cardiac hypertrophy and dysfunction induced by Gq
2002
β-Arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytes
2006 StandoutNobel
Differential myocardial gene expression in the development and rescue of murine heart failure
2003
Human Coxsackie-Adenovirus Receptor Is Colocalized With Integrins α v β 3 and α v β 5 on the Cardiomyocyte Sarcolemma and Upregulated in Dilated Cardiomyopathy
2001
The Cardiac Transcription Network Modulated by Gata4, Mef2a, Nkx2.5, Srf, Histone Modifications, and MicroRNAs
2011
β-Adrenergic Receptor Signaling: An Acute Compensatory Adjustment—Inappropriate for the Chronic Stress of Heart Failure?
2000
Contemporary Definitions and Classification of the Cardiomyopathies
2006 Standout
Spermidine in health and disease
2018 StandoutScience
Cellular and functional defects in a mouse model of heart failure
2000
From the Sarcomere to the Nucleus: Role of Genetics and Signaling in Structural Heart Disease
2000
Conversion of Phospholamban into a Soluble Pentameric Helical Bundle
2001 StandoutNobel
Antithetic regulation by β-adrenergic receptors of Gq receptor signaling via phospholipase C underlies the airway β-agonist paradox
2003 StandoutNobel
Phosphodiesterase 4D is required for β 2 adrenoceptor subtype-specific signaling in cardiac myocytes
2005 StandoutNobel
Heart Failure After Myocardial Infarction
2001
Conditional Deletion of Focal Adhesion Kinase Leads to Defects in Ventricular Septation and Outflow Tract Alignment
2007 StandoutNobel
Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure
2001 StandoutNobel
Increased Nitration of Sarcoplasmic Reticulum Ca 2+ -ATPase in Human Heart Failure
2005
Ferroptosis as a target for protection against cardiomyopathy
2019 Standout
INTRACELLULAR CALCIUM RELEASE AND CARDIAC DISEASE
2004
Cardiac responses to β‐adrenoceptor stimulation is partly dependent on mitochondrial calcium uniporter activity
2014
Targeted Deletion of MicroRNA-22 Promotes Stress-Induced Cardiac Dilation and Contractile Dysfunction
2012
Augmentation of Cardiac Contractility Mediated by the Human β 3 -Adrenergic Receptor Overexpressed in the Hearts of Transgenic Mice
2001 StandoutNobel
Anti–β1-adrenergic receptor antibodies and heart failure: causation, not just correlation
2004 StandoutNobel
DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS
2004 StandoutNobel
Phospholamban Pentamer Quaternary Conformation Determined by In-Gel Fluorescence Anisotropy,
2005
On the pivotal role of PPARa in adaptation of the heart to hypoxia and why fat in the diet increases hypoxic injury
2016 StandoutNobel
Dilated Cardiomyopathy and Sudden Death Resulting From Constitutive Activation of Protein Kinase A
2001
Is calcium the 'cure' for dilated cardiomyopathy?
1999
Phospholamban: Protein Structure, Mechanism of Action, and Role in Cardiac Function
1998
Level of β-Adrenergic Receptor Kinase 1 Inhibition Determines Degree of Cardiac Dysfunction After Chronic Pressure Overload–Induced Heart Failure
2005 StandoutNobel
What Is the Role of β-Adrenergic Signaling in Heart Failure?
2003
Impaired Cardiac Contractility Response to Hemodynamic Stress in S100A1-Deficient Mice
2002

Works of E KRANIAS being referenced

Phospholamban phosphorylation sites enhance the recovery of intracellular Ca2+ after perfusion arrest in isolated, perfused mouse heart
2006
Phospholamban regulation of bladder contractility: evidence from gene‐altered mouse models
2001
Structural and functional implications of the phospholamban hinge domain: impaired SR Ca2+ uptake as a primary cause of heart failure
2002
In vitro and in vivo promoter analyses of the mouse phospholamban gene
1997
Hsp20 and Its Cardioprotection
2005
Chronic Phospholamban–Sarcoplasmic Reticulum Calcium ATPase Interaction Is the Critical Calcium Cycling Defect in Dilated Cardiomyopathy
1999
Phospholamban and cardiac contractility
2000
Overexpression of histidine-rich Ca-binding protein protects against ischemia/reperfusion-induced cardiac injury
2007
682 Phospholamban is critically involved in beta-adrenergic receptor induced cardiac hypertrophy and failure
2003
Rankless by CCL
2026